On National Stock Exchange (NSE), the Bank of Maharashtra is quoting Rs 31.75, up 1.44%. The bank’s stock rose 51.91% in 2022, compared with the Nifty’s gain of 1.86% and the Nifty Pharma index’s gain of 52.81%.

• Vedanta Outlook for the Week (April 29, 2024 – May 03, 2024)
• Tata Steel Outlook for the Week (April 29, 2024 – May 03, 2024)
• PFC Outlook for the Week (April 29, 2024 – May 03, 2024)
• Piramal Enterprises Outlook for the Week (April 29, 2024 – May 03, 2024)
• MANAPPURAM Outlook for the Week (April 29, 2024 – May 03, 2024)

On January 13, the bank gained for a third straight session. The stock is quoting at Rs 31.75, up 1.44%. The benchmark Nifty is up around 0.33% daily, with 17,916.25. The Sensex is at 60,168.85, up 0.35%. Bank of Maharashtra has dropped around 6.89% in the previous month.

Meanwhile, the Nifty Pharma index of which Bank of Maharashtra dropped around 6.53% on December 2022 and recently traded the stock at 4,223.1, up 0.71% on the day. As of January 13, 2022, 250.78 lakh shares had traded in the stock, compared with the 732.4 lakh daily average for the previous month.

Based on TTM earnings, the PE of the stock is 12.6 as of September 2022 end.